Mimetogen Pharmaceuticals mimetogen.com


Public list: Pharma Startups (4732) Eye Health (692)

Mimetogen is actively pursuing the development of novel small molecule compounds to treat neurodegenerative diseases of the eye, including dry eye, glaucoma and retinitis pigmentosa. The company designs and develops small molecule drugs that mimic the effects of neurotrophins, proteins that help maintain the health and growth of many cells and tissues found in the eye. Making drugs that can mimic the large natural molecules may lead to the development of novel approaches to treat degenerative oc...Show all

Mimetogen is actively pursuing the development of novel small molecule compounds to treat neurodegenerative diseases of the eye, including dry eye, glaucoma and retinitis pigmentosa. The company designs and develops small molecule drugs that mimic th...Show all

Company (Alive / Active)

Phone:

Fax:

1000 de La Gauchetière Street West
Suite 900
Montreal, H3B 5H4
Quebec, Canada

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Mimetogen Pharmaceuticals $2.8M Jul 19, 2013
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Mimetogen Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors

Board Members

Competitors

Company Status Description Investors

GlycoMimetics

Gaithersburg, Maryland, United States
IPO / Went publicGlycoMimetics is developing small molecule drugs that mimic the actions of carbohydrates using glycobiology. The company is focusing its initial efforts on therapeutics to treat inflammatory diseases such as cystic fibrosis and cancer.Login to see details

MacroGenics

Rockville, Maryland, United States
IPO / Went publicMacroGenics is a biotechnology company focused on the discovery, development and delivery to patients of biologics for treatment of cancer, autoimmune disorders and infectious diseases. MacroGenics has built a fully-integrated set of capabilities in antibody-based product development which supports its innovative pipeline of clinical stage product candidates. MacroGenics' research is based on three core technology platforms, which include: (1) a leading research capability for screening and tar...Show allLogin to see details
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Beta-turn peptidomimetic cyclic compounds for treating dry eye Sep 18, 2015 Jul 18, 2017 Patent
Beta-turn peptidomimetic cyclic compounds for treating dry eye May 29, 2014 Oct 13, 2015 Patent
�-turn peptidomimetic cyclic compounds for treating dry eye Aug 31, 2012 Jun 10, 2014 Patent
Methods of treating retinitis pigmentosa Feb 26, 2010 Feb 18, 2014 Patent
Beta-turn peptidomimetic cyclic compounds for treating dry eye Apr 03, 2009 Oct 23, 2012 Patent
See all 6 patents